Document 0788 DOCN M94B0788 TI Analysis of peripheral lymphocytes of lymphoma patients for daunomycin (DNR) retention and cell differentiation antigens (Meeting abstract). DT 9412 AU Samy TS; Byrnes J; Krishan A; Harrington WJ Jr; Byrnes G; Wellham LL; Sauerteig A; Fletcher MA; University of Miami School of Medicine, Miami, FL 33136 SO Proc Annu Meet Am Assoc Cancer Res; 35:A1846 1994. Unique Identifier : AIDSLINE ICDB/94603532 AB The lymph node cells and peripheral blood lymphocytes of lymphoma patients were analyzed for cellular DNR retention, response to efflux blockers and expression of human differentiation antigens. Extensive heterogeneity in cellular DNR retention was seen in lymphocytes in 10/66 patients. Cellular DNR retention could be significantly increased by coincubation with 25 uM prochlorperazine (6/10), 10 uM verapamil (2/10) or 20 uM dipyridamole (1/10). Analysis for differentiating antigen expression showed baseline CD2, CD3, CD8 and CD25 counts significantly associated with increased survival of HIV patients while CD4, CD4 subset and B cell counts were not. Furthermore, patients with lymphocytes of CD8 counts greater than 1000 responded to chemotherapy suggesting that CD8 counts may be an important predictor for HIV associated lymphoma. These studies underscore the importance of cellular markers in diagnosis of lymphoma and suggest the use of appropriate efflux blocker or drug retention and a cytokine for CD8 cell enrichment. DE Antigens, CD/*ANALYSIS Daunorubicin/*PHARMACOKINETICS Human Lymphocyte Subsets/IMMUNOLOGY/*METABOLISM Lymphocytes/IMMUNOLOGY/*METABOLISM Lymphoma/BLOOD/*DRUG THERAPY/IMMUNOLOGY/*METABOLISM Lymphoma, AIDS-Related/BLOOD/*DRUG THERAPY/IMMUNOLOGY Prognosis MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).